Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of One-Step Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention for Patients With Multivessel Disease

NCT04811586 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT04811586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04811586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of One-Step Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention for Patients With Multivessel Disease
Lead sponsor
Shanghai East Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 30, 2020
Completion date
December 1, 2023
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multivessel coronary artery disease